XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended 15 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Cash Flows from Operating Activities:      
Net income (loss) $ 4,281,904 $ (11,644,456)  
Adjustments to reconcile net income (loss) to net cash used in operating activities:      
Interest earned on investments held in Trust Account (377,623) (51)  
Change in fair value of warrant liabilities (10,148,000) 530,000  
Change in fair value of convertible note, net - related party (365,111) 0  
Transaction costs allocated to warrant liabilities 0 1,001,129  
Initial classification of FPA liability 0 9,902,957  
Change in fair value of FPA liability 5,900,179 149,223  
Changes in operating assets and liabilities:      
Prepaid expenses 99,529 (614,569)  
Income Taxes Payable 63,771 0  
Accounts payable and accrued expenses (162,335) 30,450  
Net cash used in operating activities (707,686) (645,317)  
Cash Flows from Investing Activities:      
Investment of cash into Trust Account 0 (690,000,000)  
Cash withdrawn from Trust Account to pay franchise and income taxes 176,500 0  
Net cash provided by (used in) investing activities 176,500 (690,000,000)  
Cash Flows from Financing Activities:      
Proceeds from sale of Units, net of underwriting discounts paid 0 677,300,000  
Proceeds from sale of Private Placements Warrants 0 14,700,000  
Proceeds from convertible note 650,000 0  
Proceeds from promissory note - related party 0 300,000  
Repayment of promissory note-related party 0 (300,000)  
Payment of offering costs 0 (608,938)  
Net cash provided by financing activities 650,000 691,391,062  
Net Change in Cash 118,814 745,745  
Cash - Beginning of period 6,563 24,981 $ 24,981
Cash - End of period 125,377 770,726 $ 125,377
Non-Cash Investing and Financing Activities:      
Offering costs included in accrued offering costs 0 32,450  
Deferred underwriting fee payable $ 0 $ 22,225,000